Richard Volckmann

11.4k total citations · 1 hit paper
14 papers, 1.4k citations indexed

About

Richard Volckmann is a scholar working on Molecular Biology, Neurology and Surgery. According to data from OpenAlex, Richard Volckmann has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Neurology and 2 papers in Surgery. Recurrent topics in Richard Volckmann's work include Neuroblastoma Research and Treatments (7 papers), Epigenetics and DNA Methylation (2 papers) and Cell death mechanisms and regulation (2 papers). Richard Volckmann is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Epigenetics and DNA Methylation (2 papers) and Cell death mechanisms and regulation (2 papers). Richard Volckmann collaborates with scholars based in Netherlands, United States and Slovakia. Richard Volckmann's co-authors include Jan Köster, Rogier Versteeg, Peter van Sluis, Danny A. Zwijnenburg, Linda J. Valentijn, Nick Barker, Sorina Radulescu, Hans Clevers, Shalev Itzkovitz and Johan H. van Es and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Richard Volckmann

14 papers receiving 1.4k citations

Hit Papers

The Lgr5 intestinal stem cell signature: robust expressio... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers
    2012 562 citations Javier Muñoz, Daniel E. Stange et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Volckmann Netherlands 11 760 514 341 306 243 14 1.4k
Shigeki Yagyu Japan 20 713 0.9× 656 1.3× 164 0.5× 294 1.0× 255 1.0× 67 1.4k
Folkert H.M. Morsink Netherlands 25 484 0.6× 601 1.2× 137 0.4× 242 0.8× 132 0.5× 55 1.3k
Sílvia Regina Caminada de Toledo Brazil 23 654 0.9× 290 0.6× 113 0.3× 287 0.9× 105 0.4× 68 1.4k
Gidi Rechavi Israel 17 614 0.8× 265 0.5× 71 0.2× 113 0.4× 155 0.6× 26 1.1k
Linda Shyue Huey Chuang Singapore 17 1.0k 1.3× 347 0.7× 116 0.3× 279 0.9× 74 0.3× 27 1.4k
Shenshen Dou United States 6 482 0.6× 351 0.7× 143 0.4× 122 0.4× 267 1.1× 10 1.2k
Sudheer Kumar Gara United States 20 545 0.7× 283 0.6× 44 0.1× 260 0.8× 156 0.6× 35 1.2k
Zhiguo Chen China 19 726 1.0× 209 0.4× 356 1.0× 473 1.5× 48 0.2× 41 1.4k
Alexandre Valent France 5 1.2k 1.6× 1.2k 2.4× 102 0.3× 233 0.8× 140 0.6× 7 1.7k
Julie Maynard United Kingdom 16 829 1.1× 701 1.4× 319 0.9× 460 1.5× 251 1.0× 24 1.9k

Countries citing papers authored by Richard Volckmann

Since Specialization
Citations

This map shows the geographic impact of Richard Volckmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Volckmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Volckmann more than expected).

Fields of papers citing papers by Richard Volckmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Volckmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Volckmann. The network helps show where Richard Volckmann may publish in the future.

Co-authorship network of co-authors of Richard Volckmann

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Volckmann. A scholar is included among the top collaborators of Richard Volckmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Volckmann. Richard Volckmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Huijbers, Elisabeth J. M., Judy R. van Beijnum, Karlijn van Loon, et al.. (2025). Embryonic reprogramming of the tumor vasculature reveals targets for cancer therapy. Proceedings of the National Academy of Sciences. 122(12). e2424730122–e2424730122. 2 indexed citations
2.
Schoenmaker, Ton, Bruno G. Loos, Richard Volckmann, et al.. (2023). Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts. International Journal of Molecular Sciences. 24(7). 6822–6822. 3 indexed citations
3.
Laoukili, Jamila, Emma C. E. Wassenaar, Sjoerd G. Elias, et al.. (2022). Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity. British Journal of Cancer. 126(12). 1824–1833. 36 indexed citations
4.
Groningen, Tim van, Nurdan Akogul, Ellen M. Westerhout, et al.. (2019). A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma. Nature Communications. 10(1). 1530–1530. 95 indexed citations
5.
Bernink, Jochem H., Yoichiro Ohne, Marcel B. M. Teunissen, et al.. (2019). c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nature Immunology. 20(8). 992–1003. 151 indexed citations
6.
Köster, Jan, Richard Volckmann, Danny A. Zwijnenburg, Piet Molenaar, & Rogier Versteeg. (2019). Abstract 2490: R2: Genomics analysis and visualization platform. Cancer Research. 79(13_Supplement). 2490–2490. 17 indexed citations
7.
Köster, Jan, Richard Volckmann, Danny A. Zwijnenburg, Piet Molenaar, & Rogier Versteeg. (2019). Abstract 2490: R2: Genomics analysis and visualization platform. 2490–2490. 7 indexed citations
8.
Eleveld, Thomas F., Linda Schild, Jan Köster, et al.. (2018). RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma. Cancer Research. 78(21). 6297–6307. 40 indexed citations
9.
Valentijn, Linda J., Jan Köster, Danny A. Zwijnenburg, et al.. (2015). TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors. Nature Genetics. 47(12). 1411–1414. 255 indexed citations
10.
Muñoz, Javier, Daniel E. Stange, Arnout Schepers, et al.. (2012). The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers. The EMBO Journal. 31(14). 3079–3091. 562 indexed citations breakdown →
11.
Geerts, Dirk, Jan Köster, D.J. Albert, et al.. (2009). The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification. International Journal of Cancer. 126(9). 2012–2024. 51 indexed citations
12.
Revet, Ingrid, Jan Köster, Richard Volckmann, et al.. (2009). MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3. Cancer Letters. 289(2). 195–207. 40 indexed citations
13.
Revet, Ingrid, Alvin Chan, Jan Köster, et al.. (2007). The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta–Notch pathway in neuroblastoma. Experimental Cell Research. 314(4). 707–719. 65 indexed citations
14.
Koppen, Arjen, Jan Köster, Ingrid Øra, et al.. (2007). Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma. European Journal of Cancer. 43(16). 2413–2422. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeki Yagyu Breakdown of academic impact, for papers by Folkert H.M. Morsink Breakdown of academic impact, for papers by Sílvia Regina Caminada de Toledo Breakdown of academic impact, for papers by Gidi Rechavi Breakdown of academic impact, for papers by Linda Shyue Huey Chuang Breakdown of academic impact, for papers by Shenshen Dou Breakdown of academic impact, for papers by Sudheer Kumar Gara Breakdown of academic impact, for papers by Zhiguo Chen Breakdown of academic impact, for papers by Alexandre Valent Breakdown of academic impact, for papers by Julie Maynard
Rankless by CCL
2026